Impax Asset Management Group PLC Sarepta Therapeutics, Inc. Transaction History

Impax Asset Management Group PLC

  • $15.1 Billion
  • Q3 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$77.28 - $99.42 $186,399 - $239,801
-2,412 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$65.97 - $92.48 $159,119 - $223,061
2,412 New
2,412 $223,000
Q1 2021

May 14, 2021
SELL
$72.25 - $168.95 $163,790 - $383,009
-2,267 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$125.56 - $178.74 $284,644 - $405,203
2,267 New
2,267 $387,000

Others Institutions Holding SRPT

# of Institutions
421
Shares Held
85.8M
Call Options Held
5.66M
Put Options Held
6.11M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $1.65B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Impax Asset Management Group PLC Portfolio

Follow Impax Asset Management Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email